Evidence map›Paper›PMID 39156470›Full record

ArticleCureus2024

Autoimmune Pancreatitis Associated With Progressive Giant Multilocular Pancreatic Pseudocyst and Steroid-Induced Diabetes.

Mei Yang, Zhaoqian Zhang, Sajid Zafar

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mei YangInternal Medicine, St. Luke's Hospital, Chesterfield, USA.
Zhaoqian ZhangInternal Medicine, St. Luke's Hospital, Chesterfield, USA.
Sajid ZafarGastroenterology and Hepatology, St. Luke's Hospital, Chesterfield, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoimmune pancreatitis (AIP) is acknowledged as a benign ailment with swift responsivity to corticosteroid treatment (CST). Though past assumptions dismissed its connection to cyst formation, a few instances of AIP-linked pancreatic cysts (PCs) have been documented. While some cases responded positively to CST, others demonstrated resistance, necessitating intervention. Our case is a 50-year-old male with a known diagnosis of type 1 AIP. This case presents a specific adverse drug reaction of glucocorticoid that causes diabetes mellitus. Glucocorticoid was tapered due to clinical improvement and diabetes complications but also caused multiple flares. Additionally, in several months, CT showed progressive enlarging multi-cystic pancreatic head lesions, which cause constriction at the distal duodenal outlet and biliary ductal dilation. This case presents a specific adverse drug reaction of glucocorticoid that causes diabetes mellitus. Meanwhile, the fast-growing multi-cysts in the pancreatic head after treatment of type 1 AIP were very rare.

Indexed as

autoimmune pancreatitis (aip)giant pancreatic pseudocystpanreatitissteroid-induced diabetestype2 diabetes mellitus

Identifiers

PMID39156470
PMCPMC11330695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.